1.Current management status of hereditary colorectal cancer.
Gan Bin LI ; Zhen Jun WANG ; Jia Gang HAN
Chinese Journal of Gastrointestinal Surgery 2022;25(6):546-551
Hereditary colorectal cancer accounts for approximately 5% of all colorectal cancer cases, mainly including familial adenomatous polyposis and Lynch syndrome. Total proctocolectomy plus ileal pouch-anal anastomosis and total colectomy plus ileorectal anastomosis are two major procedures for familial adenomatous polyposis, however, the exact impact of these two procedures on surgical efficacy, oncologic efficacy as well as functional results still remains uncertain. Segmental colectomy and total colectomy are two major procedures for Lynch syndrome, each of them both has advantages and disadvantages, and there still lacks a consensus about the optimal strategy because of the nature of retrospective study with a relatively insufficient evidence support. As a result, we would make a review about the current surgical treatment status and future perspectives of hereditary colorectal cancer.
Adenomatous Polyposis Coli/surgery*
;
Anastomosis, Surgical/methods*
;
Colectomy
;
Colorectal Neoplasms, Hereditary Nonpolyposis/surgery*
;
Humans
;
Proctocolectomy, Restorative/methods*
;
Retrospective Studies
2.Therapeutic options and prognosis of synchronous multiple primary colorectal carcinomas.
Li-bin XU ; Yong-fu SHAO ; Dong-bing ZHAO ; Tie-cheng WU ; Hai-peng WANG ; Ping ZHAO
Chinese Journal of Oncology 2005;27(7):435-437
OBJECTIVETo investigate the therapeutic principles and prognosis of synchronous primary colorectal carcinomas (SCC).
METHODSThe data of 66 SCC patients surgically treated from 1984 to 2003 were retrospectively reviewed.
RESULTSThe synchronous primary colorectal carcinomas were diagnosed and resected simultaneously in 65 patients except one that was misdiagnosed. Thirty patients underwent combined resection, 35 patients segmental resection. Sixty-two patients received radical resection, while three patients had palliative resection due to hepatic metastasis. The overall postoperative 3-, 5-, 10-year survival rates were 70.3%, 60.0%, 40.6%, respectively. In the patients who had simultaneous radical resection, the 3-, 5-, 10-year survival rates were 76.0%, 65.9%, 46.4% respectively.
CONCLUSIONThe extent of resection should be individually determined by the lesion location, extent and distance between the lesions, as well as the patient's general condition. More extensive bowel resection, such as total or subtotal colectomy are suggested for those patients with hereditary nonpolyposis colorectal carcinoma syndrome in order to reduce or avoid the risk of metachronous colorectal carcinoma. The postoperative survival in patients with synchronous primary colorectal carcinoma is similar to those with solitary lesion.
Adult ; Aged ; Colorectal Neoplasms ; mortality ; pathology ; surgery ; Colorectal Neoplasms, Hereditary Nonpolyposis ; genetics ; surgery ; Female ; Humans ; Male ; Middle Aged ; Neoplasms, Multiple Primary ; genetics ; surgery ; Ovarian Neoplasms ; surgery ; Prognosis ; Stomach Neoplasms ; surgery ; Survival Rate
3.Progress in the gene diagnosis and treatment of hereditary colorectal cancer.
Tao PAN ; Yue HU ; Yin YUAN ; Su-zhan ZHANG
Chinese Journal of Oncology 2013;35(10):721-725
Adenomatous Polyposis Coli
;
diagnosis
;
drug therapy
;
genetics
;
surgery
;
Antineoplastic Agents
;
therapeutic use
;
Colectomy
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
diagnosis
;
drug therapy
;
genetics
;
surgery
;
DNA Mismatch Repair
;
Humans
;
Ileostomy
;
Peutz-Jeghers Syndrome
;
diagnosis
;
drug therapy
;
genetics
;
surgery
4.Clinicopathologic characteristics, diagnosis, and treatment of 30 patients with hereditary nonpolyposis colorectal cancer.
Heli LIU ; Zhongshu YAN ; Guoqing LIAO ; Hongling YIN ; Xiaoyong XIE
Journal of Central South University(Medical Sciences) 2009;34(8):757-761
OBJECTIVE:
To explore the clinicopathologic and molecular characteristics of hereditary nonpolyposis colorectal cancer (HNPCC), and to improve the level of diagnosis and treatments of HNPCC.
METHODS:
Thirty HNPCC patients (HNPCC group) who were treated in Xiangya Hospital were retrospectively analyzed, and 25 patients with sporadic colorectal cancer in the same duration were randomly chosen as a control group. The onset of age, location of tumor, pathological type, treatment method, and prognosis were compared in the 2 groups. The expression loss rate of mismatch repair gene (MMR) MLH1 and MSH2 in the 2 groups was detected by immunohistochemistry.
RESULTS:
The onset age in the HNPCC group was earlier than that in the control group (P<0.05). The rate of proximal colonic tumor the occurrence of multiple tumors, and the proportion of well differentiated adenocarcinoma in the HNPCC group were all higher than those in the control group (P<0.05). The expression loss rate of MLH1 and MSH2 in the HNPCC group was higher than that in the control group (P<0.05). One third in the HNPCC group received subtotal proctocolectomy. The prognosis of HNPCC patients was comparable with that of patients with sporadic colorectal cancer (P>0.05).
CONCLUSION
HNPCC patients are characterized with early onset associating with multiple tumors. The accuracy of diagnosis can be improved by combining the detection of MMR gene. Optimal surgical treatment and close follow-up may bring good result to HNPCC patients.
Adaptor Proteins, Signal Transducing
;
genetics
;
metabolism
;
Adenocarcinoma
;
diagnosis
;
genetics
;
pathology
;
surgery
;
Aged
;
Case-Control Studies
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
diagnosis
;
genetics
;
pathology
;
surgery
;
Endometrial Neoplasms
;
pathology
;
Female
;
Humans
;
Male
;
Middle Aged
;
MutL Protein Homolog 1
;
MutS Homolog 2 Protein
;
genetics
;
metabolism
;
Mutation
;
Neoplasms, Second Primary
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
Retrospective Studies
5.Lynch syndrome-related endometrial carcinoma.
Chinese Journal of Pathology 2012;41(7):494-497
Adaptor Proteins, Signal Transducing
;
metabolism
;
Adenocarcinoma, Clear Cell
;
genetics
;
metabolism
;
pathology
;
surgery
;
Adenosine Triphosphatases
;
metabolism
;
Age Factors
;
Carcinoma, Endometrioid
;
genetics
;
metabolism
;
pathology
;
surgery
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
genetics
;
metabolism
;
pathology
;
surgery
;
Cystadenocarcinoma, Serous
;
genetics
;
metabolism
;
pathology
;
surgery
;
DNA Mismatch Repair
;
DNA Repair Enzymes
;
metabolism
;
DNA-Binding Proteins
;
metabolism
;
Endometrial Neoplasms
;
genetics
;
metabolism
;
pathology
;
surgery
;
Female
;
Humans
;
Mismatch Repair Endonuclease PMS2
;
MutL Protein Homolog 1
;
MutS Homolog 2 Protein
;
metabolism
;
Neoplasms, Multiple Primary
;
genetics
;
metabolism
;
pathology
;
surgery
;
Nuclear Proteins
;
metabolism